Get the Stockscreener App
0.1335
3.26%
-0.0045
Nuwellis Inc stock is traded at $0.1335, with a volume of 1.83M.
It is down -3.26% in the last 24 hours and down -86.36% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$0.138
Open:
$0.136
24h Volume:
1.83M
Relative Volume:
1.33
Market Cap:
$1.70M
Revenue:
$8.77M
Net Income/Loss:
$-19.05M
P/E Ratio:
-0.00208
EPS:
-64.1076
Net Cash Flow:
$-11.60M
1W Performance:
-4.64%
1M Performance:
-86.36%
6M Performance:
-93.82%
1Y Performance:
-52.13%
1-Day Range:
$0.1335
$0.143
1-Week Range:
$0.1246
$0.1559
52-Week Range:
$0.1246
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.1335 | 1.70M | 8.77M | -19.05M | -11.60M | -64.11 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis Inc (NUWE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nuwellis Inc (NUWE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nuwellis Inc (NUWE) Institutional Confidence - TradingKey
Nuwellis Inc (NUWE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nuwellis Inc (NUWE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Nuwellis Inc (NUWE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuwellis Appoints Mike McCormick as CEO to Drive Growth in Cardiorenal Medical Technology - Minichart
Nuwellis provides Aquadex training to 280 physicians at summit - Investing.com
Nuwellis (NUWE) Showcases Aquadex Technology at Critical Care Su - GuruFocus
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit - The Manila Times
University of Minnesota summit puts 280 doctors on Aquadex hands-on - Stock Titan
Nuwellis Appoints Michael McCormick CEO Amid Leadership Transition - TipRanks
Nuwellis Inc (NUWE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nuwellis Inc (NUWE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nuwellis Inc (NUWE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
New Nuwellis (NASDAQ: NUWE) CEO Mike McCormick to replace John Erb on June 30, 2026 - Stock Titan
Nuwellis names Mike McCormick as CEO - MSN
Nuwellis (NUWE) Appoints New CEO in Leadership Transition - GuruFocus
Nuwellis Hires Mike McCormick as CEO - Medical Product Outsourcing
Nuwellis appoints Mike McCormick as CEO effective June 30 By Investing.com - Investing.com South Africa
Nuwellis appoints Mike McCormick as CEO effective June 30 - Investing.com
Nuwellis names Mike McCormick as CEO effective June 30, 2026, with John Erb staying as Chairman. - Pluang
Nuwellis Appoints Mike Mccormick As Chief Executive Officer - TradingView
Nuwellis, Inc. Appoints Mike McCormick as Chief Executive Officer Effective June 30, 2026 - Quiver Quantitative
Nuwellis Appoints Mike McCormick as Chief Executive Officer - The Manila Times
Press Release: Nuwellis Appoints Mike McCormick as Chief Executive Officer - Moomoo
NUWE Q1 2026 Earnings: EPS Misses Estimates by Over 100%, Shares Edge HigherAnalyst Drop Coverage - newsline.com
NUWE Q1 2026 Earnings: Significant EPS Miss Amid Missing Revenue DataTax Rate Impact - newsline.com
Nuwellis (NUWE) Slips 7.9% as Shares Test Key Support at $0.13Box Spread - newsline.com
Nuwellis shares sink after pricing $6 million equity and warrant offering (NUWE) - MSN
Nuwellis expands pediatric ultrafiltration partnership in S.C. By Investing.com - Investing.com South Africa
Nuwellis expands use of Aquadex SmartFlow® devices in South Carolina pediatric hospitals - Pluang
Nuwellis (NUWE) Expands Collaboration with South Carolina Health - GuruFocus
Nuwellis closes $6.0M registered offering, issues pre-funded warrants and Series C/D warrants - TradingView
Nuwellis (NASDAQ: NUWE) raises $6.0M in stock, pre-funded warrant and new warrant deal - Stock Titan
Nuwellis expands pediatric ultrafiltration partnership in S.C. - Investing.com
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals - The Manila Times
Children’s hospital adds Aquadex as Nuwellis readies pediatric FDA filing - Stock Titan
Nuwellis closes $6 million public offering with warrants By Investing.com - Investing.com India
Nuwellis closes $6M public offering to fund growth in cardiorenal medical tech. - Pluang
Nuwellis closes $6 million public offering with warrants - Investing.com UK
Nuwellis closes $6M public offering to fund cardiorenal medical tech development - Pluang
Nuwellis, Inc. Closes Public Offering Raising Approximately $6.0 Million - Quiver Quantitative
Medical technology firm prices $0.30 stock in $6M offering - Stock Titan
Nuwellis Announces Closing of $6.0 Million Registered Public Offering - The Manila Times
Nuwellis Announces Closing of $6.0 Million Registered Public Offering - Benzinga
Nuwellis (NASDAQ: NUWE) offers shares, pre-funded warrants and large warrant pool - Stock Titan
NUWE Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares Down SharplyRevenue Miss Report - newsline.com
Nuwellis prices $6M public offering of 20M shares with warrants at $0.30 each - Pluang
Nuwellis prices $6 million public offering at $0.30 per share - Investing.com UK
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):